MedTrace Logo

Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer

NCT00969202 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-11-18

No results posted yet for this study

Summary

The purpose of this trial is to evaluate a short course of very focused (stereotactic) external beam radiation therapy for the treatment of early stage prostate cancer.

The investigators will gather scientific information about the tolerance and side effects this type of radiation. The investigators will then compare these results with those of standard 8 week course of external beam radiation therapy to see if this study treatment is equally or more effective in treating prostate cancer.

Conditions

Interventions

RADIATION

Stereotactic Radiosurgery using the Novalis Tx

Five treatments given every other day.

Sponsors & Collaborators

  • San Diego Radiosurgery

    lead INDUSTRY

Principal Investigators

  • P. Brian Volpp, MD, MPH · San Diego Radiosurgery/X-Ray Medical Group-Radiation Oncology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2016-08-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00969202 on ClinicalTrials.gov